Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone furoate nasal spray alone versus with montelukast after FESS in chronic rhinosinusitis with asthma
ChiCTR-TRC-14004375Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in chronic rhinosinusitis (CRS) and asthma comparing Mometasone furoate nasal spray plus montelukast with Mometasone furoate nasal spray alone (2 arms). Primary endpoint: Nasal symptoms visual analog scale score. Started Jun 2014; status: recruiting.
02
Drugs
mometasonemontelukast
03
Conditions
chronic rhinosinusitis (CRS)asthma
Beyond the preview
Go deeper on ChiCTR-TRC-14004375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004375.